首页 | 本学科首页   官方微博 | 高级检索  
检索        

肝门部胆管癌32例的治疗分析
引用本文:梁旭东,杜焕社,史晓锋.肝门部胆管癌32例的治疗分析[J].中国医药,2009,4(8):900-902.
作者姓名:梁旭东  杜焕社  史晓锋
作者单位:河南科技大学第二附属医院普通外科,河南省洛阳市,471000;
摘    要:目的 分析肝门部胆管癌的治疗方法.方法 回顾性分析1998年4月至2007年12月32例肝门部胆管癌患者的治疗情况.结果 剖腹探查取活检7例(21.9%),平均存活时间为54 d.单纯胆管引流7例(21.9%),平均存活时间为5.6个月.手术切除加吻合18例(56.3%),平均存活时间为18.3个月.结论 影像学检查在肝门部胆管癌的诊断中具有重要价值;外科手术是治疗肝门部胆管癌最有效的方法;胆道引流亦可延长患者生存期;综合治疗是肝门部胆管癌治疗的方向.

关 键 词:胆管癌    胆道引流    

Therapy of 32 cases of hepatic portal cholangiocarcinoma
Abstract:Objective To observe surgical therapies of hepatic portal cholangiocarcinoma. Methods Thir-ty-two cases of hepatic portal cholangiocarcinoma between April 1998 and December 2007 were analyzed retrospec-tively. Results Average survival time of 7 cases (21.9%) of paunch ascertainment biopsy was 54 days. Average survival time of 7 cases(21.9%) of simplicity bile duct drainage was 5.6 months. Meanwhile average survival time of 18 cases (56.3%) of surgery excision and anastomosis were 18.3 months. Conclusions Image examination is of important value in diagnoses of hilar cholangiocarcinoma. Surgery is the primary method to treat hilar cholangiocarci-noma. Bile duct drainage may prolang patient's survival time and Iintegrative therapy is a direction of treating hilar cholangiocarcinoma.
Keywords:CholangiocarcinomaBile duct drainage
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号